List view / Grid view
1 July 2019 | By Vanda Dolabela de Magalhães
Purification of a drug from host cell protein contaminants can be challenging, with low-level contamination often remaining after purification. Vanda Dolabela de Magalhães shares discussions on the subject from six Brazilian companies working in the biotech field.
28 June 2019 | By Merck
Eshmuno® CP-FT cation exchange resin is specifically designed to provide efficient removal of monoclonal antibody (mAb) aggregates in the flow-through frontal chromatography mode of operation enabling loading capacities 10-times higher than traditional bind/elute CEX chromatography. It facilitates greater manufacturing flexibility and process intensification while reducing the overall cost for the…
26 June 2019 | By Thermo Fisher Scientific
ADVANCES in biotherapeutics are generating an increasing range of complex molecules that present unique and often complex purification challenges.
20 June 2019 | By European Pharmaceutical Review
In this issue we explore reasons behind critical key drug shortages in the EU, whether viability methods effectively detect all viable organisms and how companies can future-proof their digital technologies ahead of Brexit. Also included are articles on higher order protein structure, FMD compliance and Raman spectroscopy.
5 June 2019 | By European Pharmaceutical Review
The global pharmaceutical intermediates market is likely to see year-on-year growth in 2019, by an estimated 3.6 percent rate.
21 February 2019 | By Hyglos-bioMerieux
This article covers the analytical criteria that apply to Bacterial Endotoxin Testing (BET) using Limulus Amebocyte Lysate (LAL) or recombinant Horseshoe crab Factor C (rFC) for the bioactivity determination of endotoxin in aqueous solutions, such as pharmaceuticals and medical device extracts. It explains the importance of these criteria for accurate…
8 January 2019 | By European Pharmaceutical Review
The pharma corridor between Hong Kong and Brussels Airport assures handling quality for temperature-sensitive pharmaceuticals.
19 December 2018 | By Christian Cattaruzza, Dr. Sébastien Ribault, Muriel Richard
For emerging biotech and small companies in early-stage clinical development, accessing the market as quickly as possible is of paramount importance. Biopharma executives must make important decisions at this stage that will impact the success of their commercial strategy. The key to success is making the right decisions at the…
14 December 2018 | By European Pharmaceutical Review
It is paramount that manufacturers and their suppliers ensure that the quality of compounded drugs are high, by preventing risks of contamination...
13 December 2018 | By European Pharmaceutical Review
The FDA has provided guidance on data integrity and compliance; two areas extremely important for pharmaceutical businesses and manufacturers to adhere to...
27 November 2018 | By European Pharmaceutical Review
NIST researchers have shown how graphene can be modified with pores and used as an ion filter, and could be adapted for use in drug delivery systems...
26 November 2018 | By Eurofins
Companies often need to arrange for the synthesis of test substances to support research and development efforts.
26 November 2018 | By Eurofins
On 23 June 2016, the decision was made on the European Union referendum for the United Kingdom to withdraw from the European Union.
22 November 2018 | By European Pharmaceutical Review
A market report on the aspirin enteric-coated pharmaceutical industry outlines current trends and opportunities for growth from 2018 until 2023...
2 November 2018 | By Iqra Farooq (European Pharmaceutical Review)
The Endocrine Society has reported that increasing costs of insulin means that people are often deciding to forgo necessary treatment...
